Replies to post #33001 on CYduct Diagnostics Inc (CYDX)

[investorone1]

Funny you should mention those 2, they are both making money for their investors - Just thinking outloud!

[Tim H]

I think the sentiment about news isn't that there isn't great things going on already, because there are. It's more about finding the best time to buy, especially for the small guys with smaller amounts of money. And I will not make any claims about buying at any certain pps level, because it will fluctuate. As for the long term potential, sure buying ANY shares at these levels will most likely pay off.

[CBAILongShot]

It's all good, but I read the $688,000 reduction was a reduction in the net losses from the same fiscal quarter last year. Hence their loss was only about $400,00 instead of just over a million, and they expect to show a profit, or reduce losses to near zero by the end of the second quarter.

Again, all good news.

Dave

[mgrego]

It's definitely a good thought process. I would assume that once the company has achieved CE Mark certification, the first step would be to concentrate on market penetration with getting their products into research institutions and teaching hospitals in the EU (same strategy they are using domestically). Doctors probably will have already been introduced to endoscopic technology by this time and it will be a matter of having a competitive advantages (optical/video imaging for SNDY). The CE Mark just allows them to market and sell their prouduct lines in which generating revenue is the real end game. The company will more than likely see growth and profitability domestically before anywhere else and it makes sense to focus on adoption rates here. Increased adoption and success here will only help adoption in other markets.

GLTA

[Ask kicker]

Agree. SNDY doesn't release "fluff" PR's, which I find a very positive thing. When they do release news, it is truly news. We've been receiving about 1.5 a month. I'm pleased with the frequency and content. It's all good!